Bayer soars on promising trial results for stroke prevention drug

All NewsNovember 24, 2025

Findings are respite for German conglomerate facing sliding sales of blockbuster drugs and US legal challenges

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent